↓ Skip to Main Content
  • Home
  • Site Map
Vichem
  • About us
    • Vision & Mission
    • CEO
    • Strategic alliances
    • Partners
    • Top publications
    • Patent applications
  • Services
    • Fluorescent labeling of small molecules
    • Synthetic chemistry services for target identification
    • Custom synthesis
    • Contract research
    • Hit finding, assay development & screening
    • Hit to lead optimization, patentable lead generation
    • Process development & optimization
    • Liquid handling & sample management
    • Analytical Services
  • Compound libraries
    • Building blocks
    • Artemisinin derivatives
    • Nested Chemical Library™ (NCL)
    • Allosteric Library (AL)
    • Tool Compound Libary (TCL)
  • R&D projects
    • Myeloma and solid tumors
    • Development of selective FLT3 inhibitors
    • HIV
    • Other Projects
  • NRDI grants
    • TÉT_13_DST
    • KMR_12
  • EC grants
  • Pipeline
  • Contact us
Menu

Services

  • Fluorescent labeling of small molecules
  • Hit finding, assay development & screening
  • Hit to lead optimization, patentable lead generation
  • Process development & optimization
  • Custom synthesis
  • Liquid handling & sample management
  • Synthetic chemistry services for target identification

R&D projects

  • Myeloma and solid tumors
  • HIV
  • FLT3

Compound collections

  • Building blocks
  • Nested Chemical Library™ (NCL)
    Chemical Validation Library (CVL)
    Extended Validation Library (EVL)
    Master Library (ML)
  • Allosteric Library (AL)
  • Tool Compound Libary (TCL)
    © 2023 Vichem
    ↑
    The Kinase Inhibitor Company